IAIM
TVRD

International Assets Investment Management’s Tvardi Therapeutics TVRD Stock Holding History

International Assets Investment Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12 Hold
6
– – ﹤0.01% 2348
2026
Q1 		$18 Hold
6
– – ﹤0.01% 2241
2025
Q4 		$26 Buy
+6
New +$54 ﹤0.01% 2195
2021
Q2 		– Sell
-5
Closed -$3K – 1967
2021
Q1 		$3K Hold
5
– – ﹤0.01% 1963
2020
Q4 		$3K Buy
+5
New +$2.62K ﹤0.01% 1842

Other funds holding TVRD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $32B AUM 32.86% 1-Year Est. Return

International Assets Investment Management's TVRD Position: Q2 2026 in Review

International Assets Investment Management held its Tvardi Therapeutics (TVRD) position steady in Q2 2026 at 6 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

International Assets Investment Management first reported a position in TVRD in Q4 2020 and has held it in 5 quarters since. The position peaked at $3K in Q1 2021. 24 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.

  • International Assets Investment Management held 6 shares of Tvardi Therapeutics worth $12 as of Q2 2026.
  • International Assets Investment Management left its Tvardi Therapeutics share count unchanged in Q2 2026.
  • Tvardi Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2348 holding.
  • International Assets Investment Management first reported a position in Tvardi Therapeutics in Q4 2020 and has held it in 5 quarters since.
  • International Assets Investment Management's Tvardi Therapeutics position peaked at $3K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.